HaloMD, a Texas-based independent dispute resolution (IDR) firm, has appointed a new general counsel amid a series of legal challenges alleging fraudulent billing practices. The company, which specializes in navigating the complexities of the No Surprises Act (NSA), is currently facing multiple lawsuits from major insurance providers.
In May 2025, Blue Cross Blue Shield Healthcare Plan of Georgia filed a lawsuit against HaloMD and associated healthcare providers, accusing them of exploiting the NSA’s IDR process by submitting thousands of ineligible disputes. The complaint alleges that the defendants used the interstate wires to submit knowingly false attestations of eligibility for services and disputes that they knew were ineligible for the IDR process. ([ocr.docketalarm.com](https://ocr.docketalarm.com/cases/Georgia_Northern_District_Court/1–25-cv-02919/Blue_Cross_Blue_Shield_Healthcare_Plan_of_Georgia_Inc._v._HaloMD_Inc._et_al/1/?utm_source=openai))
Similarly, in June 2025, Community Insurance Company, operating as Anthem Blue Cross and Blue Shield, initiated legal action against HaloMD and related entities. The suit, filed in the U.S. District Court for the Southern District of Ohio, centers on allegations of racketeering and corrupt organization practices. ([dockets.justia.com](https://dockets.justia.com/docket/ohio/ohsdce/1%3A2025cv00388/303433?utm_source=openai))
In response to these allegations, HaloMD has denied any wrongdoing. The company maintains that its operations are compliant with federal regulations and that it is committed to ethical practices in assisting healthcare providers with the IDR process. ([americanhealthlaw.org](https://www.americanhealthlaw.org/content-library/ahla-daily/article/963d7256-3956-497d-9bd5-c59aa5efecbe/halomd-denies-allegations-in-elevance-health-billi?utm_source=openai))
The appointment of a seasoned general counsel is seen as a strategic move by HaloMD to strengthen its legal defenses and navigate the complex regulatory landscape. The new legal chief brings extensive experience in healthcare law and corporate compliance, which will be crucial as the company addresses the ongoing litigation and seeks to restore its reputation in the industry.
These developments underscore the heightened scrutiny within the healthcare sector regarding billing practices and the use of the NSA’s IDR process. As legal proceedings continue, the outcomes may have significant implications for how IDR firms operate and are regulated in the future.